Fundz

Lifespan Vision Ventures Invests In Matter Bio

PRIVATEOct 23, 2023

Round Type

Funding Round

NorwalkBiotechnologyHealth CareGenetics

Investors

Life Span Vision Ventures

Description

LifeSpan Vision Ventures today announced an investment in Matter Bio, a longevity holding company focused on preserving genome integrity. Central to the company's philosophy is that as we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. Matter Bio has assembled a world-class team of scientists and executives to help counter this critical information loss in the genome

Quick answer

Matter Bio raised an undisclosed amount in a Funding Round round, dated October 23, 2023. Investors: Life Span Vision Ventures. Matter Bio is based in Norwalk, Connecticut, United States.

How much did Matter Bio raise?
Matter Bio raised an undisclosed amount in a Funding Round round on October 23, 2023.
Who invested in Matter Bio?
Life Span Vision Ventures is named as investors in this round.
What does Matter Bio do?
Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources.
Where is Matter Bio based and how big is it?
Matter Bio is based in Norwalk, Connecticut, United States.
Who are the decision-makers at Matter Bio?
Fundz holds 1 contact at Matter Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Biotechnology around the same time

Companies in the same sectors as Matter Bio that raised within 45 days of this round, from Fundz verified event records.

  • VolitionRx raised $5.5M (Funding Round) on December 5, 2023.
  • Bionano Genomics raised $35M on October 13, 2023.
  • Ratio Therapeutics raised $51M on December 7, 2023.
  • AdvanCell raised $5M on December 7, 2023.
  • Intrommune Therapeutics, Inc. raised $210K (Seed) on December 6, 2023.
  • RxCell raised $4.6M (Seed) on December 5, 2023.

Who to call at Matter Bio, and when

A new round usually means Matter Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Matter Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Matter Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Matter Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Matter Bio

Location

Norwalk, Connecticut, United States

About

Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Matter Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Matter Bio's next move

See what Strategic adds

Matter Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.